Paz-Ares L, Garassino MC, Chen Y, Reinmuth N, et al. Durvalumab +/- tremelimumab + platinum-etoposide in extensive-stage small-cell lung cancer (CASPIAN): outcomes by PD-L1 expression and tissue tumor mutational burden. Clin Cancer Res 2023 Oct 6. doi: 10.1158/1078-0432.CCR-23-1689.
PMID: 37801329